Cardinal Health(TM) Nuclear and Precision Health Solutions Receives U.S. Food and Drug Administration Approval for New LYMPHOSEEK(R) Pediatric Indication
The new indication will provide accurate and precise lymph node identification in pediatric patients one month and older with melanoma, rhabdomyosarcoma or other types of solid tumors
DUBLIN, Ohio, June 10, 2021 -- (Healthcare Sales & Marketing Network)... Biopharmaceuticals, Radiology, Oncology, FDA Cardinal Health, LYMPHOSEEK, sentinel lymph node biopsies
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cancer & Oncology | Food and Drug Administration (FDA) | Marketing | Melanoma | Pediatrics | Pharmaceuticals | Radiology | Rhabdomyosarcoma | Skin Cancer